Canadian Cancer Trials Group Bulletins


A Cancer Research Breakthrough

A Queen's University cancer researcher, with two Canadian Cancer Trials Group members, has discovered a biomarker that will help lead to better predictions of the success of chemotherapy in ovarian cancer patients. This discovery could lead to better treatment options in the fight against ovarian cancer.

The study was conducted in collaboration with Dr. Anne-Marie Mes-Masson, who is Chair of the Canadian Cancer Trials Group Gynecology Correlative Sciences and Tumour Biology Working Group, and Dr. Jeremy Squire who, before taking up his current position in Brazil, was Director of Translational Laboratory Research at the Canadian Cancer Trials Group.

These findings were recently published in the British Journal of Cancer, which you can access using this link ...

You can view the full story on the Queen's University website using this link ...